OpenAlex
PricingAboutJobs
Log inGet started
Work

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

HTML

Year: 2009
Type: article
Source: European Journal of Clinical Investigation
DOI: 10.1111/j.1365-2362.2009.02206.x
Authors: C. Sillaber, H. Herrmann, K. Bennett, U. Rix, C. Baumgartner, A. Böhm, S. Herndlhofer, E. Tschachler, G. Superti‐Furga, U. Jäger, P. Valent
Institutions: Medical University of Vienna, Ludwig Boltzmann Institute for Hematology and Oncology, Austrian Academy of Sciences, CeMM Research Center for Molecular Medicine
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: dasatinib, chronic myeloid leukemia, imatinib resistance, immunosuppression, atypical infection, pleural effusion, weight loss, Pneumocystis carinii pneumonia, skin cancer, basophil activation, T cell activation, Lyn kinase, kinase inhibitors, adverse drug reactions
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2152024997
FWCI: 7.14
Cites: 28
Cited by: 112
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security